Stéphane Barges

Lexogen GmbH is a next generation sequencing (NGS) and transcriptomics company based in Vienna, Austria. Lexogen is the inventor of 3 RNA sequencing, a unique technology that is proven for its efficiency, robustness, and sensitivity, especially unmatched for differential gene expression analysis. The Austrian company's proprietary portfolio includes innovative kits for true single-cell as well as bulk RNA sequencing, RNA extraction, ribosomal RNA depletion, spike-in RNA variant controls, and kinetic RNA labeling. Lexogen also provides first-class, fully integrated NGS services from experimental design to analytical reporting. The mission of the Lexogen team is to empower their customers with innovative top quality RNA analysis solutions and support, in order to improve health and well-being for everyone and our planet. Thousands of scientists all over the world are using their technologies and products. The private company was founded in 2007 by Alexander Seitz, and the CEO is Stéphane Barges.